Description
Dry Injectables
Composition Artesunate 60mg
Dose Packing Dry Injections 1 Vial WHO pre-qualified Artemisinin-based Combination Therapy (ACT) ArtiferArtesunate 60mg Antimalarial therapy with demonstrated cure rates ranging from 88% to 97% in clinical studies of a 6-dose short course of therapy given over 3 days The safety and tolerability of Coartem have been studied.
• Antimalarial therapy with demonstrated cure rates ranging from 88% to 97% in clinical studies of a 6-dose short course of therapy given over 3 days
• The safety and tolerability of Coartem have been studied in both adult and pediatric patients
